"Safe" call? My thoughts on the latest mitochondrial replacement paper
By Ted Morrow,
Ted's Blog
| 06. 14. 2016
This is an important paper because it may well be the last published set of experiments from the Newcastle group (which has been developing mitochondrial replacement therapy) before the HFEA makes a decision on whether or not they are given a licence to implement pronuclear transfer (PNT) clinically. The overall message they convey is one of safety. Problems with carryover are noted and success in terms of improved efficiencies in the development of the techniques are brought to the fore (they now employ an ‘early’ version called ePNT).
From my point of view the most interesting aspect of this study is the question of mitonuclear mismatching, which is something I’ve addressed with colleagues in the past. To recap, we proposed that there is a clear possibility that when moving the nuclear genome from one ova to another, the switch from one cytoplasmic/mitochondrial background to another could be detrimental to the health of the developing embryo (this concern applies to any of the variants currently proposed or developed for mitochondrial replacement therapy). We have outlined the evidence from a range of...
Related Articles
By Azeen Ghorayshi and Sarah Kliff, The New York Times | 08.12.2024
An emerging movement against in vitro fertilization is driving some doctors and patients in red states to move or destroy frozen embryos.
The embryo migration is most striking in Alabama, where the State Supreme Court ruled in February that embryos...
By Editorial Staff, The Lancet | 07.20.2024
Image by DrKontogianniIVF from Wikimedia Commons
Despite major advances in securing sexual and reproductive rights globally, one aspect is continually neglected: infertility. Evolving gender norms and financial precariousness have led to delayed childbearing, which increases infertility in both males and...
By Staff, AP-NORC | 07.12.2024
Image by Dr. Jayesh Amin from Wikimedia Commons licensed under CC by-SA 3.0
Most adults support protecting access to in vitro fertilization, or IVF, a type of fertility treatment where eggs are combined with sperm outside the body in a...
By Julia Black and Margaux MacColl, The Information [cites CGS' Katie Hasson] | 07.19.2024
When venture capitalist Jack Abraham first began dating his wife, Gabriella Massamillo, he insisted on one condition: that when they were ready to have children, she’d be willing to conceive using in vitro fertilization. Abraham had lost both his mother...